Principal Investigator
Magdalena Tolea
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20220927
Clinical Trial Summary
A Randomized, Double-Blind, Placebo-controlled, Phase 2, 6-Month Study to Evaluate the safety, Tolerability and Exploratory Efficacy of CT1812 in Subjects with Mild to Moderate Dementia with Lewy Bodies
Phase
TBD
Funding Agency/Sponsor
Other
Disease
Memory Disorders